Vik Chopra
Stock Analyst at Wells Fargo
(1.84)
# 3,142
Out of 4,893 analysts
41
Total ratings
35.29%
Success rate
-3.81%
Average return
Main Sectors:
Stocks Rated by Vik Chopra
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MASI Masimo | Maintains: Overweight | $205 → $190 | $165.41 | +14.87% | 9 | May 7, 2025 | |
| IART Integra LifeSciences Holdings | Maintains: Equal-Weight | $25 → $13 | $13.05 | -0.38% | 2 | May 6, 2025 | |
| HSIC Henry Schein | Maintains: Equal-Weight | $80 → $75 | $74.14 | +1.16% | 2 | May 6, 2025 | |
| CNMD CONMED | Maintains: Equal-Weight | $70 → $57 | $52.91 | +7.73% | 4 | May 1, 2025 | |
| ALGN Align Technology | Maintains: Overweight | $255 → $246 | $200.48 | +22.71% | 2 | May 1, 2025 | |
| SOLV Solventum | Maintains: Equal-Weight | $73 → $75 | $74.19 | +1.09% | 3 | Feb 28, 2025 | |
| XRAY DENTSPLY SIRONA | Maintains: Equal-Weight | $20 → $19 | $16.57 | +14.67% | 2 | Feb 28, 2025 | |
| GMED Globus Medical | Maintains: Overweight | $95 → $93 | $57.31 | +62.28% | 9 | Feb 21, 2025 | |
| NVST Envista Holdings | Maintains: Equal-Weight | $20 → $21 | $20.38 | +3.04% | 2 | Feb 6, 2025 | |
| NPCE NeuroPace | Maintains: Overweight | $15 → $13 | $10.08 | +28.97% | 2 | Nov 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $26 → $19 | $11.49 | +65.36% | 1 | Aug 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $73 → $79 | $35.56 | +122.16% | 3 | Feb 23, 2024 |
Masimo
May 7, 2025
Maintains: Overweight
Price Target: $205 → $190
Current: $165.41
Upside: +14.87%
Integra LifeSciences Holdings
May 6, 2025
Maintains: Equal-Weight
Price Target: $25 → $13
Current: $13.05
Upside: -0.38%
Henry Schein
May 6, 2025
Maintains: Equal-Weight
Price Target: $80 → $75
Current: $74.14
Upside: +1.16%
CONMED
May 1, 2025
Maintains: Equal-Weight
Price Target: $70 → $57
Current: $52.91
Upside: +7.73%
Align Technology
May 1, 2025
Maintains: Overweight
Price Target: $255 → $246
Current: $200.48
Upside: +22.71%
Solventum
Feb 28, 2025
Maintains: Equal-Weight
Price Target: $73 → $75
Current: $74.19
Upside: +1.09%
DENTSPLY SIRONA
Feb 28, 2025
Maintains: Equal-Weight
Price Target: $20 → $19
Current: $16.57
Upside: +14.67%
Globus Medical
Feb 21, 2025
Maintains: Overweight
Price Target: $95 → $93
Current: $57.31
Upside: +62.28%
Envista Holdings
Feb 6, 2025
Maintains: Equal-Weight
Price Target: $20 → $21
Current: $20.38
Upside: +3.04%
NeuroPace
Nov 13, 2024
Maintains: Overweight
Price Target: $15 → $13
Current: $10.08
Upside: +28.97%
Aug 1, 2024
Maintains: Overweight
Price Target: $26 → $19
Current: $11.49
Upside: +65.36%
Feb 23, 2024
Maintains: Overweight
Price Target: $73 → $79
Current: $35.56
Upside: +122.16%